These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1970284

  • 1. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
    d'Albasio G, Trallori G, Ghetti A, Milla M, Nucci A, Pacini F, Morettini A.
    Dis Colon Rectum; 1990 May; 33(5):394-7. PubMed ID: 1970284
    [Abstract] [Full Text] [Related]

  • 2. Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis.
    Mantzaris GJ, Hatzis A, Petraki K, Spiliadi C, Triantaphyllou G.
    Dis Colon Rectum; 1994 Jan; 37(1):58-62. PubMed ID: 8287749
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis.
    Biddle WL, Greenberger NJ, Swan JT, McPhee MS, Miner PB.
    Gastroenterology; 1988 Apr; 94(4):1075-9. PubMed ID: 3278942
    [Abstract] [Full Text] [Related]

  • 7. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [Abstract] [Full Text] [Related]

  • 8. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 12. Long-term use of mesalamine enemas to induce remission in ulcerative colitis.
    Biddle WL, Miner PB.
    Gastroenterology; 1990 Jul; 99(1):113-8. PubMed ID: 1971605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
    Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA.
    Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
    [Abstract] [Full Text] [Related]

  • 15. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
    Ardizzone S, Petrillo M, Molteni P, Desideri S, Bianchi Porro G.
    J Clin Gastroenterol; 1995 Dec; 21(4):287-9. PubMed ID: 8583101
    [Abstract] [Full Text] [Related]

  • 16. Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis.
    LaRosa D, Rubin PH, Bodian C, Present DH.
    Am J Gastroenterol; 1991 Oct; 86(10):1456-60. PubMed ID: 1681725
    [Abstract] [Full Text] [Related]

  • 17. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ, May RJ.
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [Abstract] [Full Text] [Related]

  • 18. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
    Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA.
    Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
    [Abstract] [Full Text] [Related]

  • 19. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J.
    Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):1012. PubMed ID: 6127137
    [No Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P.
    Aliment Pharmacol Ther; 1989 Apr 09; 3(2):183-91. PubMed ID: 2577483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.